[Erythrocytoses in patients with dilated and ischemic cardiomyopathy.]

Area of Science:

• Cardiology
• Hematology

Background:

• Cardiovascular diseases like dilated cardiomyopathy (DCMP) and ishaemic cardiomyopathy (ICMP) are significant health concerns.
• Erythrocytosis, an increase in red blood cells, is sometimes observed in these patients, prompting investigation into its role.

Purpose of the Study:

• To evaluate the impact of erythrocytosis on cardiovascular remodelling in patients with DCMP and ICMP.
• To determine if erythrocytosis is a cause or consequence of these cardiomyopathies.

Main Methods:

• The study included patients with DCMP and ICMP, categorized by the presence or absence of erythrocytosis.
• Hemodynamic parameters and arterial blood oxygen levels were assessed.

Main Results:

• Erythrocytosis did not appear to significantly influence heart hemodynamics in patients with DCMP and ICMP.
• Patients exhibited signs of tissue hypoxia and reduced arterial oxygen levels (60.70 ± 1.24 mm Hg in DCMP, 59.60 ± 1.24 mm Hg in ICMP) compared to controls (75.44 ± 0.93 mm Hg).
• These findings suggest erythrocytosis is a consequence, not a cause, of the underlying cardiomyopathies.

Conclusions:

• Erythrocytosis in DCMP and ICMP is likely a secondary response to congestive heart failure and resulting hypoxic conditions.
• The study highlights the complex interplay between heart failure, hypoxia, and erythrocytosis.